Sindrome.del.Ovario.Poliquistico

40 Síndrome del Ovario Poliquístico
adrenal androgen regulation. J Clin
Endocrinol Metab. 1997;82:1390-6.
89
l’Allemand D, Penhoat A, Lebrethon MC,
et al. Insulin-like growth factors enhance
steroidogenic enzyme and corticotropin
receptor messenger ribonucleic
acid levels and corticotropin steroidogenic
responsiveness in cultured human
adrenocortical cells. J Clin Endocrinol
Metab. 1996;81:3892-7.
90
Cara JF. Insulin-like growth factors, insulin-like
growth factor binding proteins
and ovarian androgen production. Horm
Res. 1994;42:49-54.
91
San Millán JL, Corton M, Villuendas
G, Sancho J, Peral B, Escobar-Morreale
HF. Association of the polycystic ovary
syndrome with genomic variants related
to insulin resistance, type 2 diabetes
mellitus, and obesity. J Clin Endocrinol
Metab. 2004;89:2640-6.
92
Rudich A, Kozlovsky N, Potashnik R,
Bashan N. Oxidant stress reduces insulin
responsiveness in 3T3-L1 adipocytes.
Am J Physiol. 1997;272:E935-40.
93
Panidis D, Kourtis A, Kukuvitis A, et
al. Association of the T45G polymorphism
in exon 2 of the adiponectin gene
with polycystic ovary syndrome: role of
Delta4-androstenedione. Hum Reprod.
2004;19:1728-33.
94
Xita N, Georgiou I, Chatzikyriakidou A,
et al. Effect of adiponectin gene polymorphisms
on circulating adiponectin
and insulin resistance indexes in women
with polycystic ovary syndrome. Clin
Chem. 2005;51:416-23.
95
Witchel SF, Trivedi RN, Kammerer C.
Frequency of the T228A polymorphism
in the SORBS1 gene in children with premature
pubarche and in adolescent girls
with hyperandrogenism. Fertil Steril.
2003;80:128-32.
96
Ehrmann DA, Schwarz PE, Hara M, et al.
Relationship of calpain-10 genotype to
phenotypic features of polycystic ovary
syndrome. J Clin Endocrinol Metab.
2002;87:1669-73.
97
Haddad L, Evans JC, Gharani N, et al.
Variation within the type 2 diabetes
susceptibility gene calpain-10 and polycystic
ovary syndrome. J Clin Endocrinol
Metab. 2002;87:2606-10.
98
Escobar-Morreale HF, Peral B, Villuendas
G, Calvo RM, Sancho J, San Millán
JL. Common single nucleotide polymorphisms
in intron 3 of the calpain-10
gene influence hirsutism. Fertil Steril.
2002;77:581-7.
99
González A, Abril E, Roca A, et al.
CAPN10 alleles are associated with polycystic
ovary syndrome. J Clin Endocrinol
Metab. 2002;87:3971-6.
100
González A, Abril E, Roca A, et al.
Specific CAPN10 gene haplotypes influence
the clinical profile of polycystic
ovary patients. J Clin Endocrinol Metab.
2003;88:5529-5536.
101
Witchel SF, White C, Siegel ME, Aston
CE. Inconsistent effects of the proline12
→ alanine variant of the peroxisome
proliferator-activated receptor-gamma2
gene on body mass index in children and
adolescent girls. Fertil Steril. 2001;76:
741-7.
102
Ek J, Andersen G, Urhammer SA, et al.
Studies of the Pro12Ala polymorphism
of the peroxisome proliferator-activated
receptor-gamma2 (PPAR-gamma2) gene
in relation to insulin sensitivity among
glucose tolerant caucasians. Diabetologia.
2001;44:1170-6.
103
Hara M, Alcoser SY, Qaadir A, Beiswenger
KK, Cox NJ, Ehrmann DA. Insulin
resistance is attenuated in women
with polycystic ovary syndrome with
the Pro(12)Ala polymorphism in the
PPARgamma gene. J Clin Endocrinol
Metab. 2002;87:772-5.
104
Orio F, Matarese G, Di Biase S, et al.
Exon 6 and 2 peroxisome proliferatoractivated
receptor-g polymorphisms
in polycystic ovary syndrome. J Clin
Endocrinol Metab. 2003;88:5887-92.
105
Rajkhowa M, Talbot JA, Jones PW,
Clayton RN. Polymorphism of glycogen
synthetase gene in polycystic ovary syn-